Schedule Your Appointment Today!
Atlanta Allergy & Asthma would like to wish our employees, as well as our wonderful patients, a very Happy Thanksgiving holiday. Our clinics will be closed on Thursday and Friday so that our staff can enjoy time with their families. We will resume regular clinic hours on Monday.
Have a safe and happy holiday weekend.
Allergy Shot Reminders Now Available
We are pleased to announce a new service available to Atlanta Allergy & Asthma Immunotherapy patients. You can now sign up to receive allergy shot reminders by text and/or email. You can set these reminders to be generated when it is time for your injection, or to alert you when a shot has been missed.
Allergen Immunotherapy is a disease modifying treatment that can reduce your allergic sensitivities and provide long-term relief. When you adhere to your recommended injection schedule, over time, you will experience significant improvement in your allergic symptoms.
Please ask your injection nurse for more details.
New Treatment Options for Allergy Patients
Recently the FDA has approved several products for patients with seasonal allergic rhinitis. These tablets, which treat grass or ragweed pollen allergies, are used daily under the tongue and are called sub-lingual allergen immunotherapy (SLIT). They are indicated for allergy patients who have sensitivities to either grass or ragweed pollens, since each tablet only treats one allergen.
Although this therapy is a new option for allergy patients, as with any medical treatment, the benefits must be balanced with the potential risks. Speak with your Atlanta Allergy & Asthma physician to see if these tablets are recommended for the management of your allergies.
Participants Needed for Asthma Research Study
Atlanta Allergy & Asthma’s Research Department is looking for qualified participants for an asthma research study. We are looking for people with uncontrolled asthma. To be considered for this study, you must:
-Be between 18 and 75 years of age
-Have received an asthma diagnosis at least one year ago
-Be taking an inhaled Corticosteroid and a second controller medication for the last 6 months, with no dose changes to these medications in the 4 weeks prior to the study.
-Have asthma that is not controlled by these medications
All study-related visits, tests, and drugs will be provided at no cost. In addition, reimbursement for time and travel may be provided.
To learn more:
Stockbridge Research - 770 996-5354 or email email@example.com
Marietta Research - 770 592-4210 or email firstname.lastname@example.org
Sign Up for Our New Patient Newsletter
Subscribe to our new Allergy Update newsletter, and you'll get practice news, updates on the latest allergy and asthma research, and more.